Healthcare - Biotechnology - NASDAQ - US
$ 11.14
-3.88 %
$ 499 M
Market Cap
-20.63
P/E
CASH FLOW STATEMENT
-27.2 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
100 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Y-mAbs Therapeutics, Inc.
| Net Income | -21.4 M |
| Depreciation & Amortization | 735 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 14.5 M |
| Change in Working Capital | -19.7 M |
| Others | -5.85 M |
| Free Cash Flow | -27.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||
| Net Income | (21.4) | (95.6) | (55.3) | (119.3) | (81.0) | (43.3) | (19.2) | (17.1) |
| Depreciation & Amortization | 0.7 | 0.8 | 0.8 | 0.4 | 0.2 | 29 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 1.9 | (0.6) | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 14.5 | 25.6 | 19.3 | 16.1 | 4.7 | 2.0 | 0.6 | 0.3 |
| Other Operating Activities | (1.3) | 3.6 | (62.0) | 8.7 | 43 K | 97 K | 63 K | 2.3 |
| Change in Working Capital | (19.7) | (10.4) | (7.3) | 3.4 | 2.7 | 47 K | 2.7 | 3.4 |
| Cash From Operations | (27.2) | (75.9) | (102.6) | (91.2) | (73.5) | (41.2) | (15.9) | (11.2) |
| INVESTING CASH FLOW | ||||||||
| Capital Expenditures | 0 | 0 | (1.0) | (0.2) | (2.0) | (0.2) | 0 | 0 |
| Other Items | 0 | 0 | 62.0 | (2.6) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 61.0 | (2.8) | (2.0) | (0.2) | 0 | 0 |
| FINANCING CASH FLOW | ||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.4) |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 100 K | 84 K | 0.6 | 2.0 | 0 | (1.0) | (0.3) | 0 |
| Cash From Financing Activities | 100 K | 84 K | 108.3 | 2.0 | 134.7 | 98.8 | 89.6 | 19.0 |
| CHANGE IN CASH | ||||||||
| Net Change In Cash | (27.1) | (75.8) | 66.9 | (92.5) | 59.3 | 57.4 | 73.6 | 7.8 |
| FREE CASH FLOW | ||||||||
| Free Cash Flow | (27.2) | (75.9) | (103.5) | (91.4) | (75.5) | (41.5) | (15.9) | (11.2) |